- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Rossari Biotech reported Q3 revenue up 13% to Rs. 581.7 Cr and PAT up 3% to Rs. 32.8 Cr. The Board approved setting up greenfield specialty chemicals facilities in KSA, aiming to enhance supply chain resilience and accelerate speed-to-market.